CytoSorbents Corp.

$CTSO is making new lows for the year as its blood purification system failed a key trial.

Share this article:

About the Author:

CytoSorbents Corp.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup